Genpact Limited (NYSE:G) Shares Sold by Atria Investments Inc

Posted by Defense World Staff on Aug 28th, 2023

Atria Investments Inc trimmed its holdings in Genpact Limited (NYSE:G – Free Report) by 3.3% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 25,029 shares of the business services provider’s stock after selling 848 shares during the period. Atria Investments Inc’s holdings in Genpact were worth $1,157,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors have also recently added to or reduced their stakes in the company. Fred Alger Management LLC boosted its stake in shares of Genpact by 136.7% during the 4th quarter. Fred Alger Management LLC now owns 878 shares of the business services provider’s stock worth $41,000 after purchasing an additional 507 shares during the last quarter. Clearstead Advisors LLC acquired a new stake in shares of Genpact in the first quarter worth approximately $42,000. Ronald Blue Trust Inc. boosted its position in shares of Genpact by 71.5% in the first quarter. Ronald Blue Trust Inc. now owns 1,103 shares of the business services provider’s stock worth $51,000 after acquiring an additional 460 shares during the last quarter. Belpointe Asset Management LLC acquired a new stake in shares of Genpact in the fourth quarter worth approximately $52,000. Finally, State of Wyoming acquired a new stake in shares of Genpact in the fourth quarter worth approximately $66,000. 96.33% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Genpact news, SVP Piyush Mehta sold 41,062 shares of Genpact stock in a transaction on Thursday, June 1st. The shares were sold at an average price of $37.02, for a total value of $1,520,115.24. Following the completion of the transaction, the senior vice president now owns 135,703 shares of the company’s stock, valued at $5,023,725.06. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. In other news, SVP Piyush Mehta sold 41,062 shares of the business’s stock in a transaction on Thursday, June 1st. The shares were sold at an average price of $37.02, for a total transaction of $1,520,115.24. Following the completion of the transaction, the senior vice president now owns 135,703 shares of the company’s stock, valued at $5,023,725.06. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CEO N. V. Tyagarajan sold 1,700 shares of the business’s stock in a transaction on Wednesday, August 16th. The shares were sold at an average price of $35.89, for a total transaction of $61,013.00. Following the transaction, the chief executive officer now directly owns 8,300 shares of the company’s stock, valued at approximately $297,887. The disclosure for this sale can be found here. Insiders sold a total of 64,844 shares of company stock valued at $2,401,033 over the last 90 days. 2.62% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

G has been the topic of several research analyst reports. JPMorgan Chase & Co. cut shares of Genpact from a “neutral” rating to an “underweight” rating and set a $40.00 target price on the stock. in a research report on Tuesday, August 22nd. Wedbush restated a “neutral” rating and issued a $45.00 price target on shares of Genpact in a report on Thursday, August 10th. StockNews.com started coverage on shares of Genpact in a report on Thursday, August 17th. They issued a “buy” rating on the stock. TheStreet lowered shares of Genpact from a “b-” rating to a “c+” rating in a research note on Friday, June 9th. Finally, Jefferies Financial Group dropped their price objective on shares of Genpact from $47.00 to $41.00 in a research note on Monday, May 15th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $42.13.

Read Our Latest Stock Analysis on G

Genpact Stock Up 1.3 %

G stock opened at $36.63 on Monday. The company has a market capitalization of $6.64 billion, a P/E ratio of 16.73, a PEG ratio of 1.42 and a beta of 1.19. The firm has a 50 day simple moving average of $37.31 and a 200-day simple moving average of $41.00. The company has a current ratio of 1.88, a quick ratio of 1.88 and a debt-to-equity ratio of 0.64. Genpact Limited has a twelve month low of $35.31 and a twelve month high of $48.85.

Genpact Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 26th. Shareholders of record on Friday, September 8th will be issued a $0.1375 dividend. This represents a $0.55 dividend on an annualized basis and a yield of 1.50%. The ex-dividend date is Thursday, September 7th. Genpact’s dividend payout ratio is presently 25.11%.

Genpact Company Profile

(Free Report)

Genpact Limited provides business process outsourcing and information technology (IT) services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The company offers CFO advisory services; and environmental, social, and governance (ESG) services, such as data management, carbon accounting, human rights assessment, sustainability diligence, and ESG reporting.

Institutional Ownership by Quarter for Genpact (NYSE:G)

Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.